SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

Add to Watch List

Set Alert

4.83 Data as of 12:17pm ET	-0.02 / -0.41% Today’s Change	3.68 Today\|\|\|52-Week Range 7.58	+12.07% Year-to-Date

4.83

Data as of 12:17pm ET

-0.02 / -0.41%

Today’s Change

3.68

Today|||52-Week Range

7.58

+12.07%

Year-to-Date

SECTOR

Health Technology

INDUSTRY

Pharmaceuticals: Other

MARKET CAP

$261.9M

Company Description

SciClone Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer and infectious diseases. The company operates through two segments: China and Rest of the World including United States. It is a pharmaceutical company with a substantial commercial business in China a product portfolio of therapies for oncology, infectious diseases and cardiovascular, urological, respiratory and central nervous system disorders. Its ZADAXIN (thymalfasin) is approved in over 30 countries and may be used for the treatment of hepatitis B (HBV), hepatitis C (HCV), as a vaccine adjuvant, and certain cancers. The company was founded in 1990 and is headquartered in Foster City, CA.

Contact Information

SciClone Pharmaceuticals, Inc.

950 Tower Lane

Foster City California 94404-2125

P:(650) 358-3456

Investor Relations:
(650) 358-1447

www.sciclone.com

Employees

Shareholders

Mutual fund holders	28.67%
Other institutional	26.66%
Individual stakeholders	14.19%

Top Executives

Friedhelm Blobel, PhD	President, Chief Executive Officer & Director
Gary S. Titus, CPA	CFO, Senior Vice President & Head-Media Relations
Cynthia W. Tuthill, PhD	Chief Scientific Officer & SVP-Scientific Affairs
Deryck Wade	Senior Director-Clinical Operations
Paolo Cavazza	Principal

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.